Selecta Biosciences, Inc. Distinguished as World Economic Forum Technology Pioneer 2014
Published: Aug 27, 2013
WATERTOWN, Mass.--(BUSINESS WIRE)--Selecta Biosciences, innovator of immune targeting Synthetic Vaccine Particles (SVP™), has been awarded Technology Pioneer 2014 by the World Economic Forum. Selecta is one of 36 emerging technology companies from around the world and across all industries recognized for their potential to make a global impact based on groundbreaking technology. Selecta has established its SVP platform to develop novel vaccines and immunotherapeutics to address two priorities in global health: advanced medicines that offer broader prevention and treatment of serious diseases with unmet needs; and advanced medicines that offer compelling economics to readily enable distribution and use by patients in both developed and emerging countries.
Help employers find you! Check out all the jobs and post your resume.